medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2014, Number 4

<< Back Next >>

Acta Med Cent 2014; 8 (4)

Thrombolysis in brain vascular disease

Jiménez LM, Díaz PE, Ulloa QF

Language: Spanish
References: 10
Page: 84-87
PDF size: 65.72 Kb.


ABSTRACT

Ischemic stroke is the leading cause of disability and the third death in modern society. The end result after a stroke depends on the speed and quality of treatment, starting at implementing strategies to reduce the delay, both extra and intra-hospital, in health care. Assistance includes patient stabilization, with special attention to the maintenance of the airway, and the management of blood pressure and heart rate. The initial assessment should be quick and be focused on the differential diagnosis, the estimating of the size and location of the infarction, as well as consideration of therapies. Among them, the only currently approved is thrombolysis with intravenous recombinant tissue plasminogen activator or blood in selected patients with a clinical course of less than three hours.


REFERENCES

  1. Bembibre R, Soto A, Díaz D, Hernández A. Epidemiología de la enfermedad cerebrovascular hemorrágica en la región central de Cuba. Rev Ecuat Neurol [Internet]. 2002 [citado 10 May 2006];11(1-2):[aprox. 3 p.]. Disponible en: http://wwwmedicosecuador.com/revecuatneurol/vol11_n1- 2002/epidemiologia_de_la.htm

  2. Schwamm LH, Fonarow GC, Reeves MJ. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009 Jan 6;119(1):107-15. doi: 10.1161/CIRCULATIONAHA.108.783688.

  3. Rozman C. Farreras Medicina interna. 14ª ed. [CD-ROM] Madrid: Harcourt; 2000.

  4. Goldstein JN, Marrero M, Masrur S. Management of thrombolysis associated symptomatic intracerebral hemorrhage. Arch Neurol. 2010 Aug;67(8):965-9. doi: 10.1001/archneurol.2010.175.

  5. Leira EC. Manejo del ictus agudo. Rev Esp Neurol. 2003;36:86-92 PMID: 12577221

  6. Bruce C, Campbell V, Hans T, Christense S, Desmond P. Assessing Response to Stroke Thrombolysis. Validation of 24-Hour Multimodal Magnetic Resonance Imaging. Arch Neurol. 2012 Jan;69(1):46-50.

  7. Totah A. Thrombolysis, Fluctuations, and Protocol Expansions. Arch Neurol. 2009;66(3):416-421. doi:10.1001/archneurol.2008

  8. Reeves MJ, Smith E, Fonarow G, Hernandez A, Pan W, Schwamm LH. GWTG -Stroke Steering Committee & Investigators. Off-hour admission and in-hospital stroke case fatality in the Get With the Guidelines Stroke program. Stroke. 2009 Feb;40(2):569- 76.

  9. Ropper AH, Samuels M. Enfernmedades cerebrovasculares. En: Adams & Victor’s Principles of Neurology. 9th ed. Mexico: McGraw-Hill Interamericana; 2009. p. 544- 615.

  10. Philip I, Ropper AH. Enfermedades cerebrovasculares. En: Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson L. Harrison's Principles of Internal Medicine. 16 th ed. México. D.F: McGraw-Hill Interamericana; 2006. p. 2348-84.




2020     |     www.medigraphic.com